This promotional meeting is intended for UK/IE healthcare professionals only and is organised and funded by LEO Pharma. LEO Pharma medicines will be discussed at this meeting. Prescribing information and adverse event reporting for Enstilar® cutaneous foam (calcipotriol/betamethasone dipropionate) can be found below.

Promotional section of the meeting

Time Item Speaker
19:15-19:30 Welcome and Introduction Rose Dodd, Dermatology Account Manager, LEO Pharma
“Diagnosis, short- and long-term management of adult plaque psoriasis in primary care Dr Aruni Ranasinghe, Consultant Dermatologist, West Suffolk Hospital
19:30-19:40 Scalp Psoriasis Case Study Dr Sidra Khan, Specialist Registrar in Dermatology, Salford Royal NHS Foundation Trust

Enstilar® is indicated for the topical treatment of psoriasis vulgaris (plaque psoriasis) in adults only. Patients who have responded at 4 weeks’ treatment once daily are suitable for long-term maintenance treatment

Non-Promotional section of the meeting

Time Item Speaker
19:45-20:30 Virtual Dermatology Clinic Part 2 Dr Sidra Khan
20:30-20:45 Questions and Close